RAYMOND JAMES & ASSOCIATES - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-63.6%
71,417
+7.5%
0.00%
Q2 2022$11,000
-65.6%
66,417
-1.3%
0.00%
Q1 2022$32,000
-15.8%
67,3030.0%0.00%
Q4 2021$38,000
-89.4%
67,303
-68.7%
0.00%
Q3 2021$357,000
-1.1%
214,803
-0.6%
0.00%
Q2 2021$361,000
+11.1%
216,072
+12.4%
0.00%
Q1 2021$325,000
+5.9%
192,155
-0.3%
0.00%
Q4 2020$307,000
+67.8%
192,769
+0.7%
0.00%
Q3 2020$183,000
+47.6%
191,400
-1.5%
0.00%
Q2 2020$124,000
+49.4%
194,400
-2.5%
0.00%
Q1 2020$83,000
-28.4%
199,400
+0.5%
0.00%
Q4 2019$116,000
+20.8%
198,500
+3.9%
0.00%
Q3 2019$96,000
+74.5%
191,000
+35.5%
0.00%
Q2 2019$55,000
-22.5%
141,000
+11.9%
0.00%
Q1 2019$71,000
+1083.3%
126,000
+687.5%
0.00%
Q4 2018$6,000
-85.0%
16,000
-79.6%
0.00%
Q3 2018$40,000
-70.4%
78,329
+27.2%
0.00%
Q2 2018$135,000
-32.8%
61,584
+4.2%
0.00%
Q1 2018$201,000
+46.7%
59,084
+75.7%
0.00%
Q4 2017$137,000
+1612.5%
33,630
+110.2%
0.00%
Q2 2017$8,000
-38.5%
16,0000.0%0.00%
Q1 2017$13,000
-13.3%
16,000
-2.4%
0.00%
Q4 2016$15,000
+66.7%
16,400
+32.3%
0.00%
Q3 2016$9,00012,4000.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders